We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+20.73%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$498B
AUM Growth
+$25.7B
Cap. Flow
-$8.9B
Cap. Flow %
-1.79%
Top 10 Hldgs %
16.86%
Holding
2,648
New
135
Increased
1,180
Reduced
817
Closed
125

Sector Composition

Rank Sector Weight
1 Healthcare 18.56%
2 Consumer Discretionary 15.28%
3 Financials 14.93%
4 Technology 13.43%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVVI icon
2451
Willamette Valley Vineyards
WVVI
$11.8M
$86K ﹤0.01%
10,850
EPE
2452
DELISTED
EP Energy Corporation
EPE
$85K ﹤0.01%
19,407
-16,893
-47% -$70.5K
BDSI
2453
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$85K ﹤0.01%
31,500
PW
2454
Power REIT
PW
$2.79M
$83K ﹤0.01%
1,013
REFR icon
2455
Research Frontiers
REFR
$16M
$82K ﹤0.01%
31,600
CRDF icon
2456
Cardiff Oncology
CRDF
$81.7M
$80K ﹤0.01%
247
CARM
2457
DELISTED
Carisma Therapeutics
CARM
$79K ﹤0.01%
+1,410
New +$105K
HBIO icon
2458
Harvard Bioscience
HBIO
$30M
$77K ﹤0.01%
2,820
SOHO
2459
DELISTED
Sotherly Hotels
SOHO
$77K ﹤0.01%
14,600
NBSE
2460
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$76K ﹤0.01%
67
III icon
2461
Information Services Group
III
$244M
$75K ﹤0.01%
18,686
+86
+0.5% +$333
AIOT
2462
PowerFleet Inc
AIOT
$419M
$75K ﹤0.01%
15,300
ALR
2463
DELISTED
AlerisLife Inc
ALR
$75K ﹤0.01%
3,940
-10
-0.3% -$214
HTCH
2464
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$75K ﹤0.01%
18,800
CBR
2465
DELISTED
CIBER Inc.
CBR
$74K ﹤0.01%
64,340
QMCO icon
2466
Quantum Corp
QMCO
$964M
$73K ﹤0.01%
618
IIP
2467
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$73K ﹤0.01%
44,500
EVRI
2468
DELISTED
Everi Holdings
EVRI
$71K ﹤0.01%
28,700
ZIXI
2469
DELISTED
Zix Corporation
ZIXI
$71K ﹤0.01%
17,300
+100
+0.6% +$395
RT
2470
DELISTED
Ruby Tuesday Georgia
RT
$71K ﹤0.01%
28,400
RFP
2471
DELISTED
Resolute Forest Products Inc.
RFP
$69K ﹤0.01%
14,600
LTS
2472
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$69K ﹤0.01%
29,700
ENZ
2473
DELISTED
Enzo Biochem, Inc.
ENZ
$67K ﹤0.01%
13,255
+155
+1% +$926
TTPH
2474
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$65K ﹤0.01%
845
TCS
2475
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$64K ﹤0.01%
850
+3
+0.4% +$242

Similar funds

T. Rowe Price Associates's Q3 2016 Portfolio in Review

As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
  • T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
  • T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
  • T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
  • T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
  • T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
  • T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.